TMR's report on the global medical radioisotopes market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global medical radioisotopes market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global medical radioisotopes market from 2025 to 2035.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the medical radioisotopes market.
Market Snapshot
Market Value in 2024
US$ 5.9 Bn
Market Value in 2035
US$ 14.1 Bn
CAGR
8.1%
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global medical radioisotopes market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global medical radioisotopes market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global medical radioisotopes market.
The report delves into the competitive landscape of the global medical radioisotopes market. Key players operating in the global medical radioisotopes market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global medical radioisotopes market profiled in this report.
Key Questions Answered in global medical radioisotopes Market Report:
What is the sales/revenue generated by medical radioisotopes across all regions during the forecast period?
What are the opportunities in the global medical radioisotopes market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2035?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
Medical Radioisotopes Market - Research Objectives and Research Approach
The comprehensive report on the global medical radioisotopes market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global medical radioisotopes market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global medical radioisotopes market.
Table of Contents
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Medical Radioisotopes Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Medical Radioisotopes Market Analysis and Forecast, 2020-2035
4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
5.1. Recent Advancements
5.2. PORTER's Five Forces Analysis
5.3. PESTEL Analysis
5.4. Value Chain Analysis
5.5. Key Industry Events (Mergers, Acquisitions, Partnerships, Collaborations, etc.)
5.6. Pricing Analysis (Brand pricing, Average Selling Price by Region/Country)
5.7. Regulatory Scenario by Key Country
5.8. Research and Development Trends
5.9. Go-to-Market Strategy for New Market Entrants
6. Global Medical Radioisotopes Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Type, 2020-2035
6.3.1. Technetium-99m
6.3.2. Gallium-67
6.3.3. Iodine-131
6.3.4. Copper-67
6.3.5. Cobalt-60
6.3.6. Strontium-82
6.3.7. Germanium-68
6.3.8. Rubidium-82
6.3.9. Thallium-201
6.3.10. Others
6.4. Market Attractiveness Analysis, by Type
7. Global Medical Radioisotopes Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2020-2035
7.3.1. Cardiology
7.3.2. Oncology
7.3.3. Neurology
7.3.4. Nephrology
7.3.5. Thyroid
7.3.6. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Medical Radioisotopes Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2020-2035
8.3.1. Hospitals
8.3.2. Diagnostics Centers
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Medical Radioisotopes Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2035
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Medical Radioisotopes Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Type, 2020-2035
10.2.1. Technetium-99m
10.2.2. Gallium-67
10.2.3. Iodine-131
10.2.4. Copper-67
10.2.5. Cobalt-60
10.2.6. Strontium-82
10.2.7. Germanium-68
10.2.8. Rubidium-82
10.2.9. Thallium-201
10.2.10. Others
10.3. Market Value Forecast, by Application, 2020-2035
10.3.1. Cardiology
10.3.2. Oncology
10.3.3. Neurology
10.3.4. Nephrology
10.3.5. Thyroid
10.3.6. Others
10.4. Market Value Forecast, by End-user, 2020-2035
10.4.1. Hospitals
10.4.2. Diagnostics Centers
10.4.3. Others
10.5. Market Value Forecast, by Country, 2020-2035
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Medical Radioisotopes Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Type, 2020-2035
11.2.1. Technetium-99m
11.2.2. Gallium-67
11.2.3. Iodine-131
11.2.4. Copper-67
11.2.5. Cobalt-60
11.2.6. Strontium-82
11.2.7. Germanium-68
11.2.8. Rubidium-82
11.2.9. Thallium-201
11.2.10. Others
11.3. Market Value Forecast, by Application, 2020-2035
11.3.1. Cardiology
11.3.2. Oncology
11.3.3. Neurology
11.3.4. Nephrology
11.3.5. Thyroid
11.3.6. Others
11.4. Market Value Forecast, by End-user, 2020-2035
11.4.1. Hospitals
11.4.2. Diagnostics Centers
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2020-2035
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Medical Radioisotopes Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Type, 2020-2035
12.2.1. Technetium-99m
12.2.2. Gallium-67
12.2.3. Iodine-131
12.2.4. Copper-67
12.2.5. Cobalt-60
12.2.6. Strontium-82
12.2.7. Germanium-68
12.2.8. Rubidium-82
12.2.9. Thallium-201
12.2.10. Others
12.3. Market Value Forecast, by Application, 2020-2035
12.3.1. Cardiology
12.3.2. Oncology
12.3.3. Neurology
12.3.4. Nephrology
12.3.5. Thyroid
12.3.6. Others
12.4. Market Value Forecast, by End-user, 2020-2035
12.4.1. Hospitals
12.4.2. Diagnostics Centers
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2020-2035
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Medical Radioisotopes Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Type, 2020-2035
13.2.1. Technetium-99m
13.2.2. Gallium-67
13.2.3. Iodine-131
13.2.4. Copper-67
13.2.5. Cobalt-60
13.2.6. Strontium-82
13.2.7. Germanium-68
13.2.8. Rubidium-82
13.2.9. Thallium-201
13.2.10. Others
13.3. Market Value Forecast, by Application, 2020-2035
13.3.1. Cardiology
13.3.2. Oncology
13.3.3. Neurology
13.3.4. Nephrology
13.3.5. Thyroid
13.3.6. Others
13.4. Market Value Forecast, by End-user, 2020-2035
13.4.1. Hospitals
13.4.2. Diagnostics Centers
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2020-2035
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Medical Radioisotopes Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Type, 2020-2035
14.2.1. Technetium-99m
14.2.2. Gallium-67
14.2.3. Iodine-131
14.2.4. Copper-67
14.2.5. Cobalt-60
14.2.6. Strontium-82
14.2.7. Germanium-68
14.2.8. Rubidium-82
14.2.9. Thallium-201
14.2.10. Others
14.3. Market Value Forecast, by Application, 2020-2035
14.3.1. Cardiology
14.3.2. Oncology
14.3.3. Neurology
14.3.4. Nephrology
14.3.5. Thyroid
14.3.6. Others
14.4. Market Value Forecast, by End-user, 2020-2035
14.4.1. Hospitals
14.4.2. Diagnostics Centers
14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-region, 2020-2035
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of Companies)